• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Fluid/Blood Leak (1250)
Patient Problem Failure of Implant (1924)
Event Date 10/09/2016
Event Type  malfunction  
Manufacturer Narrative
The reporter of the event was asked to return the product for analysis.The device has not yet been received by apollo.Device labeling addresses the reported event of deflation as follows: warnings and precautions: the risk of balloon deflation and intestinal obstruction (and therefore possible death related to intestinal obstruction) is significantly higher when balloons are left in place longer than 6 months or used at larger volumes (greater than 700 cc).Deflated devices should be removed promptly.The physiological response of the patient to the presence of the orbera system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Complications: possible complications of the use of the orbera system include: balloon deflation and subsequent replacement.
 
Event Description
Reported as: a patient with the orbera intragastric balloon had bluish urine.The "balloon ruptured." the device has been removed.
 
Manufacturer Narrative
Medwatch sent to fda on 08/02/2017.Device evaluation summary: a visual examination was performed on the received balloon noted to be discolored, the shell was dark bluish green in appearance, and the valve was light brown in appearance.White particles were noted on the inner and outer surfaces of the shell.An opening was noted on the radius of the shell of the balloon approximately three inches away from the center patch/valve.As the device was note returned with a fill tube, a sample fill tube was used for further device testing.A valve test was performed, and noted the flow of di water was continuous and unobstructed.An air leak test was performed, and leakage was noted from one tear on the posterior portion of the device shell.The tear was approximately two inches in length.Under microscopic analysis, the apparent origination point of the tear was noted to be striated, and consistent with device removal activities.White particulate matter of an unknown origin was noted to be attached to the valve channel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia
Manufacturer Contact
laura leboeuf
1120 s capitol of texas hwy
bldg 1, ste 300
austin, TX 78746
5122795100
MDR Report Key6136162
MDR Text Key61151315
Report Number3006722112-2016-00360
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/21/2017
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot Number2793366
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/04/2016
Initial Date FDA Received11/30/2016
Supplement Dates Manufacturer Received07/25/2017
Supplement Dates FDA Received08/02/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/21/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age42 YR
Patient Weight79
-
-